Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of summary of stock option activity (Details)

v3.21.2
Stock-Based Compensation - Schedule of summary of stock option activity (Details) - $ / shares
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Number of Shares      
Balance at the beginning (in shares)   22,050,000  
Granted (in shares)   700,000  
Exercised (in shares) (106,250) (106,250)  
Cancelled (in shares)   (753,750)  
Forfeited (in shares)   (40,000)  
Balance at the ending (in shares) 21,850,000 21,850,000 22,050,000
Exercisable (in shares) 6,130,000 6,130,000  
Vested and expected to vest (in shares) 21,850,000 21,850,000  
Weighted Average Exercise Price      
Balance outstanding (in dollars per share) $ 0.07 $ 0.07 $ 0.06
Granted (in dollars per share)   0.16  
Exercised (in dollars per share)   0.05  
Cancelled (in dollars per share)   0.05  
Forfeited (in dollars per share)   0.05  
Exercisable (in dollars per share) 0.11 0.11  
Vested and expected to vest (in dollars per share) $ 0.07 $ 0.07  
Weighted Average Remaining Contractual Term (Years)      
Weighted average remaining contractual term (years)   9 years 18 days 9 years 6 months 7 days
Weighted average remaining contractual term (years), exercisable   8 years 8 months 19 days  
Weighted average remaining contractual term (years), vested and expected to vest   9 years 18 days